You are here: Industry Insights > BioNTech

News List

Pfizer, BioNTech Partner with Biovac for COVID-19 Vax in Africa contractpharma
July 22, 2021
Biovac will perform manufacturing and distribution activities within Pfizer’s and BioNTech’s global COVID-19 vaccine supply chain and manufacturing network.
BioNTech to purchase Kite manufacturing facility and cell therapy R&D platform cphi-online
July 22, 2021
The acquisition will add manufacturing footprint in the US enabling the company to develop its pipeline of novel cancer product candidates
New advice issued on COVID-19 vaccination of children and young people pharmatimes
July 21, 2021
The UK’s Joint Committee on Vaccination and Immunisation (JCVI) has advised that children with an increased risk of serious illness from COVID-19 should be offered the Pfizer/BioNTech vaccine.
BioNTech to Acquire Kite’s TCR Cell Therapy Platform and Mfg. Facility contractpharma
July 20, 2021
BioNTech SE and Kite, a Gilead Company, have entered a purchase agreement for BioNTech to acquire Kite’s solid tumor neoantigen T cell receptor (TCR) R&D platform and clinical manufacturing facility in Gaithersburg, MD.
Covid-19: At-risk children to be offered Pfizer/BioNTech vaccine firstwordpharma
July 20, 2021
UK health secretary Sajid Javid said children who are at increased risk of COVID-19 will be offered Pfizer/BioNTech's vaccine on the NHS "as soon as possible," as are those who are immunocompromised, as reported in This is Money.
Pfizer-BioNTech’s Covid-19 vaccine receives FDA priority review pharmaceutical-technology
July 19, 2021
The US Food and Drug Administration (FDA) has granted priority review designation to biologics license application (BLA) submitted by Pfizer and BioNTech for their Covid-19 vaccine.
Report finds almost 100% of people tested positive for antibodies after second vaccine dose pharmatimes
July 16, 2021
A new report from Imperial College London and Ipsos MORI has shown that almost 100% of people tested positive for antibodies 14 days after their second dose of the Pfizer/BioNTech or AstraZeneca COVID-19 vaccines.
PHE study finds COVID-19 vaccines ‘highly effective’ in at-risk groups pharmatimes
July 13, 2021
A new study from Public Health England (PHE) has found COVID-19 vaccine are as effective at preventing symptomatic disease in most people in clinical risk groups as the rest of the population.
Israel offers Pfizer COVID-19 vaccine booster shots to adults at risk firstwordpharma
July 12, 2021
Israel said on Sunday it will start offering a booster of Pfizer COVID-19 vaccine BNT162b2 to adults with impaired immune systems, but it was still considering whether a third round of shots should be given to the general public, as reported in Fidelity.
Israel reports decrease in Pfizer vaccine effectiveness against infections expresspharma
July 08, 2021
The decline coincided with the spread of the Delta variant and the end of social distancing restrictions in Israel.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 20 21 Next page